These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 26278815)
1. Detection of mitotic figures in thin melanomas--immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain. Ottmann K; Tronnier M; Mitteldorf C J Am Acad Dermatol; 2015 Oct; 73(4):637-44. PubMed ID: 26278815 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma. Ikenberg K; Pfaltz M; Rakozy C; Kempf W J Cutan Pathol; 2012 Mar; 39(3):324-30. PubMed ID: 22335591 [TBL] [Abstract][Full Text] [Related]
3. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500 [TBL] [Abstract][Full Text] [Related]
4. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas. Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284 [TBL] [Abstract][Full Text] [Related]
5. Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast. Ginter PS; Shin SJ; Liu Y; Chen Z; D'Alfonso TM Hum Pathol; 2016 Mar; 49():90-8. PubMed ID: 26826415 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215 [TBL] [Abstract][Full Text] [Related]
7. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma. Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936 [TBL] [Abstract][Full Text] [Related]
8. Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma. Casper DJ; Ross KI; Messina JL; Sondak VK; Bodden CN; McCardle TW; Glass LF Am J Dermatopathol; 2010 Oct; 32(7):650-4. PubMed ID: 20559123 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of efficacy of 1% Crystal Violet & Nuclear Fast Red stain compared to Haematoxyline & Eosin stain for assessing mitotic figures in oral premalignant and malignant lesions. Motiwale G; Jaiswal S; Vikey A; Motiwale T; Bagulkar B; Bhat A; Kapoor P J Exp Ther Oncol; 2016 Jul; 11(3):165-170. PubMed ID: 28471120 [TBL] [Abstract][Full Text] [Related]
10. Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain. Thareja S; Zager JS; Sadhwani D; Thareja S; Chen R; Marzban S; Jukic DM; Glass LF; Messina J Am J Dermatopathol; 2014 Jan; 36(1):64-7. PubMed ID: 24451214 [TBL] [Abstract][Full Text] [Related]
11. Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas. Drabeni M; Lopez-Vilaró L; Barranco C; Trevisan G; Gallardo F; Pujol RM Am J Dermatopathol; 2013 Feb; 35(1):56-63. PubMed ID: 22688397 [TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma. Ladstein RG; Bachmann IM; Straume O; Akslen LA J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638 [TBL] [Abstract][Full Text] [Related]
13. Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds. Duregon E; Cassenti A; Pittaro A; Ventura L; Senetta R; Rudà R; Cassoni P Neuro Oncol; 2015 May; 17(5):663-9. PubMed ID: 25646026 [TBL] [Abstract][Full Text] [Related]
14. Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis. Glatz K; Hartmann C; Antic M; Kutzner H Am J Dermatopathol; 2010 Oct; 32(7):643-9. PubMed ID: 20661119 [TBL] [Abstract][Full Text] [Related]
15. Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma. Nielsen PS; Riber-Hansen R; Schmidt H; Steiniche T Diagn Pathol; 2016 Apr; 11():35. PubMed ID: 27062658 [TBL] [Abstract][Full Text] [Related]
16. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574 [TBL] [Abstract][Full Text] [Related]
17. pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas. Schimming TT; Grabellus F; Roner M; Pechlivanis S; Sucker A; Bielefeld N; Moll I; Schadendorf D; Hillen U Am J Dermatopathol; 2012 May; 34(3):266-9. PubMed ID: 22197861 [TBL] [Abstract][Full Text] [Related]
18. Comparison of staining of mitotic figures by haematoxylin and eosin-and crystal violet stains, in oral epithelial dysplasia and squamous cell carcinoma. Ankle MR; Kale AD; Charantimath S Indian J Dent Res; 2007; 18(3):101-5. PubMed ID: 17687171 [TBL] [Abstract][Full Text] [Related]
19. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis. Hale CS; Qian M; Ma MW; Scanlon P; Berman RS; Shapiro RL; Pavlick AC; Shao Y; Polsky D; Osman I; Darvishian F Am J Surg Pathol; 2013 Jun; 37(6):882-9. PubMed ID: 23629443 [TBL] [Abstract][Full Text] [Related]
20. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma. Duregon E; Molinaro L; Volante M; Ventura L; Righi L; Bolla S; Terzolo M; Sapino A; Papotti MG Mod Pathol; 2014 Sep; 27(9):1246-54. PubMed ID: 24434900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]